<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01164384</url>
  </required_header>
  <id_info>
    <org_study_id>BamiHepC-Study</org_study_id>
    <nct_id>NCT01164384</nct_id>
  </id_info>
  <brief_title>A Phase 1b, Single Center, Clinical Study to Investigate the Safety and Biological Responses to Baminercept in Patients With Chronic HCV Hepatitis.</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Zurich</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>PD Dr. rer. nat. Mathias Heikenw√§lder</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Zurich</source>
  <brief_summary>
    <textblock>
      Erstes Safety Trial mit Baminercept in chronischen HCV Patienten. Untersuchung des potentiell
      antiviralen, antiinflammatorischen Effekts sowie Modulation der hepatischen Gen-Expression.

      10 Patienten, open label, 10 Wochen Therapie. Sequentielles Enrollement der ersten 4
      Patienten.

        -  Trial with medicinal product
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>October 2010</start_date>
  <completion_date>February 2013</completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Sicherheit</measure>
  </primary_outcome>
  <condition>Chronic HCV Hepatitis C</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Baminercept</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria: Informed consent Age 18-60 years Chronic HCV infection Non responder
        (to Peg-IFN alpha2/Ribavirin containing therapy) Elevated ALT Liver biopsy at screening
        without sings of (pre-)cirrhosis Compensated liver function Absolute neutrophil count &gt;
        1500 / mm3 at screening Hemoglobin &gt; 10 g/dL at screening Calculated creatinine clearance
        of &gt; 60 cc/min at screening Normal TSH at screening

        Exclusion criteria: HBV infection Evidence for concomitant liver disease other than HCV
        hepatitis Evidence for a HCC Alpha-fetoprotein &gt;20ng/ml Autoimmune Disease ANA &gt; 1/320,
        documented in the last 6 months HIV 1/2 infection ALT and AST &gt;3x ULN, alkaline phosphatase
        &gt;2,5x ULN Known hypersensitivity or allergy to Baminercept Other clinically significant
        concomitant disease states Known or suspected non-compliance to study protocol, drug or
        alcohol abuse Infections other than HCV hepatitis Clinically important chest x-ray
        abnormality at screening Body mass index (BMI) &gt; 30kg/m2 Concomitant systemic
        immunosuppressive/-modulating therapy Treatment with anticoagulants Receipt of live vaccine
        within 4 weeks prior to study start Symptomatic hypogammaglobulinemia with history of
        recurrent infections Subjects with a history of malignant disease Treatment with other
        investigational products or participation in an interventional clinical trial within the
        last 3 months Pregnancy or Breastfeeding Inability or refusal to practice a safe
        contraception
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>01 Studienregister MasterAdmins</last_name>
    <role>Study Director</role>
    <affiliation>UniversitaetsSpital Zuerich</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>01 Studienregister MasterAdmins</last_name>
    <phone>+41 (0)44 255 11 11</phone>
  </overall_contact>
  <location>
    <facility>
      <address>
        <city>Zurich</city>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>July 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 8, 2010</study_first_submitted>
  <study_first_submitted_qc>July 15, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 16, 2010</study_first_posted>
  <last_update_submitted>July 15, 2010</last_update_submitted>
  <last_update_submitted_qc>July 15, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 16, 2010</last_update_posted>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hepatitis</mesh_term>
    <mesh_term>Hepatitis C</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

